In addition to Orai1, its close paralogue, Orai3, has been shown to mediate Stim1-triggered SOCE in oestrogen receptor positive (ER+) breast cancer [12] and non-small cell lung adenocarcinoma [13] cell lines. Here, ORAI1 is linked to breast carcinoma.